Results
75,408 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 33 | Grayson Blake JeffreyChief Financial Officer |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $2.10M 30.0K sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 33 | Grayson Blake JeffreyChief Financial Officer | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $2.10M 30.0K sh |
| Sep 8, 2026 traded Sep 4, 2026 |
| 33 | Gehring Rob L.CEO, Americas |  MNSTMonster Beverage CorpTax withholding | F | $386K 8,760 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 32 | Berho Carranza DiegoChief Portfolio Officer |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $22K 6,219 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Sever MichalCMO |  NYAXNayax Ltd.Open-market sale | SELL | $1,779 34 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | McLaughlin Matthew F.Director, Chief Executive Officer |  SCORCOMSCORE, INC.Open-market purchase | BUY | $84K 16.6K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $255K 9,705 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Prosor MayaChief Business Officer |  LMNDLemonade, Inc.Open-market sale | SELL | $57K 1,040 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 31 | Speth RalfDirector |  SHMDSCHMID Group N.V.Grant or award | A | $96K 16.3K sh | Sep 8, 2026 traded May 23, 2026 |
| 31 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale | SELL | $249K 5,666 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 30 |  Mike KellyRSpouse | New Jersey St 19 GO Emer Go 5% due 6/1/28 Sale | SELL | $50K – $100K | Sep 8, 2026 traded Aug 28, 2026 |
| 30 | Mike KellyRSpouse | Mississippi St Ref Go P/R 10/1/27 5% due 10/1/31 Sale | SELL | $50K – $100K | Sep 8, 2026 traded Aug 17, 2026 |
| 29 | Manor SagitCFO | NYAXNayax Ltd. Open-market sale | SELL | $6,444 123 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 29 | Furman Carly LisanneCEO NAYX North America | NYAXNayax Ltd. Open-market sale | SELL | $5,022 96 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 29 | Greenberg Aaron SamuelCSO | NYAXNayax Ltd. Open-market sale | SELL | $4,028 77 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 28 | Courtis Kenneth S.Director |  AMRAlpha Metallurgical Resources, Inc.Open-market purchase | BUY | $413K 1,847 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 28 | Courtis Kenneth S.Director | AMRAlpha Metallurgical Resources, Inc. Open-market purchase | BUY | $656K 2,891 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 28 | Courtis Kenneth S.Director | AMRAlpha Metallurgical Resources, Inc. Open-market purchase | BUY | $475K 2,109 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 28 | Lantheus Alpha Therapy, LLC10% Owner |  CATXPerspective Therapeutics, Inc.Open-market sale | SELL | $526K 167.1K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 28 | Courtis Kenneth S.Director | AMRAlpha Metallurgical Resources, Inc. Open-market purchase | BUY | $622K 2,749 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 27 | Cao Sean WuxiongChief Bus. Development Officer |  NBPNovaBridge BiosciencesOption exercise | M | — 235.1K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 27 | Kraemer Richard SSEVP & CFO |  FULTFULTON FINANCIAL CORPOption exercise | M | — 14.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 27 | Gehring Rob L.CEO, Americas | MNSTMonster Beverage Corp Option exercise | M | — 20.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 27 | Cao Sean WuxiongChief Bus. Development Officer | NBPNovaBridge Biosciences Option exercise | M | — 45.3K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 27 | Kraemer Richard SSEVP & CFO | FULTFULTON FINANCIAL CORP Option exercise | M | — 14.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 27 | Polak Aldo J.Director |  EVTCEVERTEC, Inc.Open-market sale | SELL | $33K 1,094 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 27 | Kraemer Richard SSEVP & CFO | FULTFULTON FINANCIAL CORP Other acquisition or disposition | J | $2,500 136 sh | Sep 8, 2026 traded Jun 6, 2026 |
| 26 | Grayson Blake JeffreyChief Financial Officer | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $754K 11.6K sh | Sep 8, 2026 traded Sep 8, 2026 |
| 26 | Kraemer Richard SSEVP & CFO | FULTFULTON FINANCIAL CORP Tax withholding | F | $125K 5,219 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 25 | Courtis Kenneth S.Director | AMRAlpha Metallurgical Resources, Inc. Open-market purchase | BUY | $70K 305 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 25 |  Lloyd DoggettDSelf |  PGPROCTER & GAMBLE CoPurchase | BUY | $1,001 – $15K | Sep 8, 2026 traded Aug 17, 2026 |
| 25 | Mansharamani LeenaSVP, Chief Accounting Officer |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $87K 2,558 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 25 | McLaughlin Matthew F.Director, Chief Executive Officer | SCORCOMSCORE, INC. Open-market purchase | BUY | $17K 3,367 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 24 | Keller FrankPres., Checkout Sol. & PayPal |  PYPLPayPal Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $133K 2,427 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 24 | Schlosser MarioDirector |  OSCROscar Health, Inc.Open-market sale · 10b5-1 plan | SELL | $988K 31.4K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 24 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $4.63M 45.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 23 | Cao Sean WuxiongChief Bus. Development Officer | NBPNovaBridge Biosciences Option exercise | M | — 104.2K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 23 | McAnaney AdamChief Legal Officer | OSCROscar Health, Inc. Open-market sale · 10b5-1 plan | SELL | $286K 9,092 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 23 | Agress Adam LEVP Business Development |  KTCCKEY TRONIC CORPOption exercise | M | — 3,695 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 23 | Courtney Mark RVice President of Supply Chain | KTCCKEY TRONIC CORP Option exercise | M | — 1,847 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 23 | Cao Sean WuxiongChief Bus. Development Officer | NBPNovaBridge Biosciences Option exercise | M | — 102.2K sh | Sep 8, 2026 traded Sep 3, 2026 |